First Look Analysts Research Calls for Friday, February 3

Photo of Paul Ausick
By Paul Ausick Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
First Look Analysts Research Calls for Friday, February 3

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Cardinal Health (CAH) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $94

> H.B. Fuller (FUL) upgraded to Buy from Neutral at Citigroup; tgt raised to $85

> Int’l Paper (IP) upgraded to Neutral from Sell at UBS; tgt raised to $43

> Nordstrom (JWN) upgraded to Hold from Reduce at Gordon Haskett; tgt $22

Downgrades:

> Aptiv (APTV) downgraded to Peer Perform from Outperform at Wolfe Research

> Boeing (BA) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt $225

> C.H. Robinson (CHRW) downgraded to Hold from Buy at Stifel; tgt lowered to $99

> Camden Property (CPT) downgraded to Neutral from Overweight at Piper Sandler; tgt $136

> Cognizant Tech (CTSH) downgraded to Neutral from Outperform at Robert W. Baird; tgt raised to $68

> First Foundation (FFWM) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $16

> Focus Financial (FOCS) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $53

> Ford Motor (F) downgraded to Sell from Hold at Deutsche Bank; tgt lowered to $11

> Generac (GNRC) downgraded to Neutral from Buy at Guggenheim

> Hexcel (HXL) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $70

> Hilton Grand Vacations (HGV) downgraded to Hold from Buy at Jefferies; tgt lowered to $52

> Spirit Aerosystems (SPR) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt lowered to $36

> Travel + Leisure Co (TNL) downgraded to Hold from Buy at Jefferies; tgt lowered to $49

Others:

> Agios Pharma (AGIO) initiated with an Overweight at Piper Sandler; tgt $41

> Day One Biopharmaceuticals (DAWN) initiated with a Perform at Oppenheimer

> Herbalife Nutrition (HLF) initiated with an Underperform at BofA Securities; tgt $14

> Privia Health (PRVA) initiated with a Buy at Goldman; tgt $32

> Relay Therapeutics (RLAY) initiated with an Outperform at Oppenheimer; tgt $33

> Tyra Biosciences (TYRA) initiated with an Outperform at Oppenheimer; tgt $17

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618